Leukemia, Myelogenous, Chronic, BCR-ABL Positive
"Leukemia, Myelogenous, Chronic, BCR-ABL Positive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
MeSH Number(s)
C04.557.337.539.250
C15.378.190.636.370
Concept/Terms
Leukemia, Myelogenous, Chronic, BCR-ABL Positive- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid, Philadelphia-Positive
- Leukemia, Granulocytic, Chronic
- Myeloid Leukemia, Chronic
- Chronic Myeloid Leukemia
- Chronic Myeloid Leukemias
- Leukemia, Chronic Myeloid
- Leukemias, Chronic Myeloid
- Myeloid Leukemias, Chronic
- Leukemia, Myeloid, Chronic
- Leukemia, Myelocytic, Chronic
- Myelocytic Leukemia, Chronic
- Chronic Myelocytic Leukemia
- Chronic Myelocytic Leukemias
- Leukemia, Chronic Myelocytic
- Leukemias, Chronic Myelocytic
- Myelocytic Leukemias, Chronic
- Leukemia, Myelogenous, Chronic
- Leukemia, Myelogenous, Ph1 Positive
- Leukemia, Myelogenous, Ph1-Positive
- Myelogenous Leukemia, Ph1-Positive
- Leukemia, Ph1-Positive Myelogenous
- Leukemias, Ph1-Positive Myelogenous
- Myelogenous Leukemia, Ph1 Positive
- Myelogenous Leukemias, Ph1-Positive
- Ph1-Positive Myelogenous Leukemia
- Ph1-Positive Myelogenous Leukemias
- Leukemia, Myeloid, Ph1 Positive
- Leukemia, Myeloid, Ph1-Positive
- Myeloid Leukemia, Ph1-Positive
- Leukemia, Ph1-Positive Myeloid
- Leukemias, Ph1-Positive Myeloid
- Myeloid Leukemia, Ph1 Positive
- Myeloid Leukemias, Ph1-Positive
- Ph1-Positive Myeloid Leukemia
- Ph1-Positive Myeloid Leukemias
- Myelogenous Leukemia, Chronic
- Chronic Myelogenous Leukemia
- Chronic Myelogenous Leukemias
- Leukemia, Chronic Myelogenous
- Leukemias, Chronic Myelogenous
- Myelogenous Leukemias, Chronic
- Leukemia, Myeloid, Philadelphia Positive
- Myeloid Leukemia, Philadelphia-Positive
- Leukemia, Philadelphia-Positive Myeloid
- Leukemias, Philadelphia-Positive Myeloid
- Myeloid Leukemia, Philadelphia Positive
- Myeloid Leukemias, Philadelphia-Positive
- Philadelphia-Positive Myeloid Leukemia
- Philadelphia-Positive Myeloid Leukemias
- Granulocytic Leukemia, Chronic
- Chronic Granulocytic Leukemia
- Chronic Granulocytic Leukemias
- Granulocytic Leukemias, Chronic
- Leukemia, Chronic Granulocytic
- Leukemias, Chronic Granulocytic
Below are MeSH descriptors whose meaning is more general than "Leukemia, Myelogenous, Chronic, BCR-ABL Positive".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Myelogenous, Chronic, BCR-ABL Positive".
This graph shows the total number of publications written about "Leukemia, Myelogenous, Chronic, BCR-ABL Positive" by people in Harvard Catalyst Profiles by year, and whether "Leukemia, Myelogenous, Chronic, BCR-ABL Positive" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 7 | 1 | 8 |
1994 | 8 | 6 | 14 |
1995 | 4 | 5 | 9 |
1996 | 4 | 4 | 8 |
1997 | 5 | 4 | 9 |
1998 | 12 | 2 | 14 |
1999 | 6 | 3 | 9 |
2000 | 7 | 2 | 9 |
2001 | 8 | 4 | 12 |
2002 | 10 | 2 | 12 |
2003 | 8 | 7 | 15 |
2004 | 10 | 4 | 14 |
2005 | 12 | 1 | 13 |
2006 | 10 | 5 | 15 |
2007 | 12 | 2 | 14 |
2008 | 11 | 6 | 17 |
2009 | 10 | 2 | 12 |
2010 | 15 | 5 | 20 |
2011 | 11 | 3 | 14 |
2012 | 17 | 0 | 17 |
2013 | 11 | 2 | 13 |
2014 | 16 | 1 | 17 |
2015 | 13 | 2 | 15 |
2016 | 12 | 3 | 15 |
2017 | 12 | 4 | 16 |
2018 | 14 | 1 | 15 |
2019 | 14 | 2 | 16 |
2020 | 12 | 1 | 13 |
2021 | 9 | 0 | 9 |
2022 | 15 | 0 | 15 |
2023 | 5 | 0 | 5 |
Below are the most recent publications written about "Leukemia, Myelogenous, Chronic, BCR-ABL Positive" by people in Profiles.
-
Characterization of K562 cells: uncovering novel chromosomes, assessing transferrin receptor expression, and probing pharmacological therapies. Cell Mol Life Sci. 2023 Aug 14; 80(9):248.
-
Anxiety exacerbation in a patient with chronic myeloid leukemia receiving dasatinib and venlafaxine. J Oncol Pharm Pract. 2023 Oct; 29(7):1762-1765.
-
The Impact of Improved Treatments on Survival of Adult U.S. Leukemia Patients: 1990-2018. Cancer Epidemiol Biomarkers Prev. 2023 06 01; 32(6):744-747.
-
Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis. Haematologica. 2023 06 01; 108(6):1567-1578.
-
Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results. Leukemia. 2023 05; 37(5):1048-1059.
-
Cognition in patients treated with targeted therapy for chronic myeloid leukemia: a controlled comparison. Leuk Lymphoma. 2023 02; 64(2):415-423.
-
Secondary fusion proteins as a mechanism of BCR::ABL1 kinase-independent resistance in chronic myeloid leukaemia. Br J Haematol. 2023 02; 200(3):323-328.
-
Ex Vivo Expansion of Phenotypic and Transcriptomic Chronic Myeloid Leukemia Stem Cells. Exp Hematol. 2022 11; 115:1-13.
-
Ponatinib after failure of second-generation tyrosine kinase inhibitor in resistant chronic-phase chronic myeloid leukemia. Am J Hematol. 2022 11; 97(11):1419-1426.
-
Prevalence and Clinical Characteristics of Paraproteinemia Associated with Chronic Myeloid Leukemia. Acta Haematol. 2022; 145(6):619-626.